Scholar IQ
Try ScholarIQ free
Upload Records Snowball Search Search OpenAlex
About the database
ScholarIQanswers from OpenAlex

Soluble Programmed Cell Death Ligand 1 as a Novel Biomarker for Nivolumab Therapy for Non–Small-cell Lung Cancer

PaperCitations, authors & open-access status

Soluble Programmed Cell Death Ligand 1 as a Novel Biomarker for Nivolumab Therapy for Non–Small-cell Lung Cancer is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 146 citations, 2018 year and closed oa status.

146
Citations
2018
Year
closed
OA Status

Related on ScholarIQ

Yusuke Okuma
Author
Clinical Lung Cancer
Journal
Cancer Immunotherapy and Biomarkers
Topic
Cancer Immunotherapy and Biomarkers
Topic
Lung Cancer Research Studies
Topic
Lung Cancer Treatments and Mutations
Topic
470M+ articles · free account